CURE — DIREXION SHS ETF TR

Ownership history in Summit Financial, LLC  ·  2 quarters on record

This page tracks every 13F SEC filing in which Summit Financial, LLC reported a position in DIREXION SHS ETF TR (CURE). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 ADDED 2,831 +19 +0.7% 0.00% $316K $111.56
2025 Q3 INITIATED 2,812 — — 0.00% $235K $83.31
% of Fund (quarterly)    CURE price (monthly, adj. close)

Other funds also holding CURE

As of 2025 Q4 — sorted by position size

Bullseye Investment Management, LLC 3Y 1.06% GTS SECURITIES LLC 0.09% Frazier Financial Advisors, LLC 0.07% Virtu Financial LLC 3Y 7Y 0.06% Traynor Capital Management, Inc. 3Y 7Y 0.03% Onyx Bridge Wealth Group LLC 3Y 0.03% Tower Research Capital LLC (TRC) 3Y 7Y 0.02% Pinnacle Wealth Planning Services, Inc. 3Y 7Y 0.01% SUSQUEHANNA INTERNATIONAL GROUP, LLP 3Y 7Y 0.0% JANE STREET GROUP, LLC 3Y 7Y 0.0%
← Back to Summit Financial, LLC Holdings